| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | Y | 1 Tissue for MammaPrint testing | 960 | 584 | 478 | 282 | 143 | 46 | 10 | 11/27/2023 | 376 | 133 |
| 584 | 478 | 282 | 143 | 46 | 10 | |||||||||
| 2 | Y | 2 SOC Chemotherapy | 99 | 84 | 51 | 26 | 8 | 3 | 11/27/2023 | |||||
| 3 SOC Chemotherapy + Durvalumab | 98 | 83 | 52 | 29 | 11 | 2 | ||||||||
| 197 | 167 | 103 | 55 | 19 | 5 | |||||||||
| S2212-Breast, TNBC, Neoadj Chemo + Pembro | 1 | Y | 1 Carbo + Paclitaxel + Pembro -> AC + Pembro | 2400 | 364 | 266 | 148 | 81 | 33 | 7 | 09/15/2023 | 380 | 147 | |
| 2 Carbo + Docetaxel + Pembro | 369 | 269 | 151 | 81 | 31 | 8 | ||||||||
| 733 | 535 | 299 | 162 | 64 | 15 | |||||||||
| Yes | A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib | 1 | E | Total Registrations | 55 | 11 | 4 | 1 | 0 | 0 | 03/11/2021 | 438 | 206 | |
| 55 | 11 | 4 | 1 | 0 | 0 | |||||||||
| A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab | 1 | E | Total Registrations | 33 | 25 | 18 | 12 | 3 | 0 | 08/24/2023 | 375 | 185 | ||
| 33 | 25 | 18 | 12 | 3 | 0 | |||||||||
| MA39-BREAST, Node-Pos, Reg RT vs No Reg RT | 1 | E | Total Registrations | 59 | 28 | 16 | 7 | 3 | 2 | 10/18/2019 | 406 | 154 | ||
| 59 | 28 | 16 | 7 | 3 | 2 | |||||||||
| 2 | E | Total Registrations | 57 | 27 | 15 | 7 | 3 | 2 | 10/18/2019 | |||||
| 57 | 27 | 15 | 7 | 3 | 2 | |||||||||
| NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | T | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | 145 | 55 | ||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | T | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 06/22/2018 | ||||
| 7 | 0 | 0 | 0 | 0 | 0 | |||||||||
| No | A012301-Breast, Early Stg, Tamoxifen | 1 | E | Total Registrations | 7 | 7 | 7 | 6 | 3 | 1 | 03/07/2025 | 341 | 99 | |
| 7 | 7 | 7 | 6 | 3 | 1 | |||||||||
| EA1211-Breast, HER2+, NeoAdj Therapy | 1 | E | Total Registrations | 9 | 7 | 3 | 1 | 1 | 0 | 05/06/2024 | 128 | 58 | ||
| 9 | 7 | 3 | 1 | 1 | 0 | |||||||||
| NRGBR007-Breast, Stg I, De-Escalation of Breast RT | 1 | E | Total Registrations | 25 | 16 | 8 | 3 | 1 | 0 | 06/01/2022 | 402 | 177 | ||
| 25 | 16 | 8 | 3 | 1 | 0 | |||||||||
| 2 | E | Total Registrations | 23 | 14 | 7 | 3 | 1 | 0 | 06/01/2022 | |||||
| 23 | 14 | 7 | 3 | 1 | 0 | |||||||||
| NRGBR008-Breast, LowRisk HER2+, Radiotherapy | 1 | E | Total Registrations | 1 | 1 | 1 | 0 | 0 | 0 | 03/10/2025 | 8 | 3 | ||
| 1 | 1 | 1 | 0 | 0 | 0 | |||||||||
| NRGBR009-Breast, EarlyStg, Adjuvant Chemo | 1 | E | Total Registrations | 15 | 12 | 7 | 4 | 1 | 0 | 01/31/2024 | 453 | 192 | ||
| 15 | 12 | 7 | 4 | 1 | 0 | |||||||||
| 2 | E | Total Registrations | 15 | 12 | 7 | 4 | 1 | 0 | 01/31/2024 | |||||
| 15 | 12 | 7 | 4 | 1 | 0 | |||||||||